ClinConnect ClinConnect Logo
Search / Trial NCT06295510

Observational Study of the Association Between Food Intake and Endometrial Polyps

Launched by QINXIU ZHANG · Feb 28, 2024

Trial Information

Current as of July 05, 2025

Not yet recruiting

Keywords

Diet Endometrial Polyp Women Milk Tea

ClinConnect Summary

This clinical trial is looking to understand how what we eat might affect the development of endometrial polyps, which are growths in the lining of the uterus. Currently, there’s no research on the link between diet and these polyps, and this study aims to fill that gap. By examining the relationship between food intake and the occurrence of endometrial polyps, the researchers hope to provide better guidelines for preventing these growths in women.

The study is open to women who have been diagnosed with endometrial polyps and can complete a food intake questionnaire on their own. However, women with other serious health conditions or mental illnesses will not be eligible to participate. Since the trial is not yet recruiting participants, those interested will need to wait for it to begin. If you choose to join, you can expect to share information about your eating habits, which may help improve future recommendations for women’s health.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Consistent with the international clinical diagnosis of endometrial polyps.Can complete content recall alone.
  • Exclusion Criteria:
  • No other mental diseases. Not associated with other major diseases, including tumors, immune system diseases

About Qinxiu Zhang

Qinxiu Zhang is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Qinxiu Zhang oversees the design and implementation of rigorous clinical trials across various therapeutic areas. Their expertise in clinical development and a strong adherence to ethical standards ensures that all trials conducted under their guidance prioritize patient safety and data integrity. Through a strategic approach to research, Qinxiu Zhang aims to contribute significantly to the scientific community and enhance the landscape of healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

Qinxiu Zhang

Study Director

Hospital of Chengdu University of Traditional Chinese Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported